Literature DB >> 19335226

Role of matching in case-control studies of antimicrobial resistance.

Elizabeth Cerceo1, Ebbing Lautenbach, Darren R Linkin, Warren B Bilker, Ingi Lee.   

Abstract

Of 57 case-control studies of antimicrobial resistance, matching was used in 23 (40%). Matched variables differed substantially across studies. Of these 23 matched case-control studies, 12 (52%) justified the use of matching, and 9 (39%) noted the strengths or limitations of this approach. Analysis that accounted for matching was performed in only 52% of the case-control studies.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19335226      PMCID： PMC2767121          DOI： 10.1086/597061

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  26 in total

1.  Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

Authors:  A Soriano; J A Martínez; J Mensa; F Marco; M Almela; A Moreno-Martínez; F Sánchez; I Muñoz; M T Jiménez de Anta; E Soriano
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

Review 2.  Matching criteria in case-control studies on postoperative infections.

Authors:  M E Falagas; E G Mourtzoukou; F Ntziora; G Peppas; P I Rafailidis
Journal:  J Hosp Infect       Date:  2008-03-10       Impact factor: 3.926

Review 3.  The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions.

Authors:  M J Struelens
Journal:  BMJ       Date:  1998-09-05

Review 4.  Antimicrobial-drug resistance.

Authors:  H S Gold; R C Moellering
Journal:  N Engl J Med       Date:  1996-11-07       Impact factor: 91.245

5.  A retrospective, case-control study of acyclovir resistance in herpes simplex virus.

Authors:  Denis Malvy; Michèle Treilhaud; Stéphane Bouée; Anne Crochard; Denis Vallée; Abdelkader El Hasnaoui; Michele Aymard
Journal:  Clin Infect Dis       Date:  2005-06-14       Impact factor: 9.079

6.  Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Erika J Ernst; George Raley; Loreen A Herwaldt; Daniel J Diekema
Journal:  Infect Control Hosp Epidemiol       Date:  2005-07       Impact factor: 3.254

7.  Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men.

Authors:  Nolan E Lee; Melanie M Taylor; Elizabeth Bancroft; Peter J Ruane; Margie Morgan; Lucie McCoy; Paul A Simon
Journal:  Clin Infect Dis       Date:  2005-04-13       Impact factor: 9.079

8.  Risk factors for and clinical outcomes of bloodstream infections caused by extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Cheol-In Kang; Sung-Han Kim; Dong Min Kim; Wan Beom Park; Ki-Deok Lee; Hong-Bin Kim; Myoung-Don Oh; Eui-Chong Kim; Kang-Won Choe
Journal:  Infect Control Hosp Epidemiol       Date:  2004-10       Impact factor: 3.254

9.  Increased mortality associated with a clonal outbreak of ceftazidime-resistant Klebsiella pneumoniae: a case-control study.

Authors:  Abdul Qavi; Sorana Segal-Maurer; Noriel Mariano; Carl Urban; Carl Rosenberg; Janice Burns; Tom Chiang; James Maurer; James J Rahal
Journal:  Infect Control Hosp Epidemiol       Date:  2005-01       Impact factor: 3.254

10.  Multidrug-resistant Acinetobacter baumannii.

Authors:  Aharon Abbo; Shiri Navon-Venezia; Orly Hammer-Muntz; Tami Krichali; Yardena Siegman-Igra; Yehuda Carmeli
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883
View more
  1 in total

Review 1.  Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance.

Authors:  Vered Schechner; Elizabeth Temkin; Stephan Harbarth; Yehuda Carmeli; Mitchell J Schwaber
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.